Cann Group Limited (ASX:CAN)
0.0040
0.00 (0.00%)
Jul 10, 2026, 12:55 PM AEST
Cann Group Market Cap
Cann Group has a market cap or net worth of 7.31 million as of July 10, 2026. Its market cap has increased by 14.97% in one year.
Market Cap
7.31M
Enterprise Value
21.32M
Revenue
11.31M
Ranking
n/a
PE Ratio
0.22
Stock Price
0.00
Market Cap Chart
Since May 4, 2017, Cann Group's market cap has decreased from 69.89M to 7.31M, a decrease of -89.53%. That is a compound annual growth rate of -21.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 7.31M | -48.26% |
| Dec 31, 2025 | 14.14M | -32.38% |
| Dec 31, 2024 | 20.91M | -50.25% |
| Dec 29, 2023 | 42.03M | -47.23% |
| Dec 30, 2022 | 79.65M | -21.27% |
| Dec 31, 2021 | 101.17M | -36.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syntara | 45.12M |
| Peak Processing | 19.73M |
| Vitura Health | 18.56M |
| IDT Australia | 13.68M |
| Epsilon Healthcare | 8.56M |
| Argent BioPharma | 8.00M |
| ECS Botanics Holdings | 7.98M |
| Percheron Therapeutics | 5.33M |